Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiency (Q80147709)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429342 AND SRC:MED&resulttype=core&format=json

29 December 2019

title

Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiency (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429342 AND SRC:MED&resulttype=core&format=json

29 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429342 AND SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Brown NJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429342 AND SRC:MED&resulttype=core&format=json

29 December 2019

Bradford J

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429342 AND SRC:MED&resulttype=core&format=json

29 December 2019

Wang Z

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429342 AND SRC:MED&resulttype=core&format=json

29 December 2019

Ma L

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429342 AND SRC:MED&resulttype=core&format=json

29 December 2019

Ma J

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429342 AND SRC:MED&resulttype=core&format=json

29 December 2019

Vaughan DE

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429342 AND SRC:MED&resulttype=core&format=json

29 December 2019

Fogo AB

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429342 AND SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

11 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429342 AND SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429342 AND SRC:MED&resulttype=core&format=json

29 December 2019

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429342 AND SRC:MED&resulttype=core&format=json

29 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429342 AND SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

72-81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429342 AND SRC:MED&resulttype=core&format=json

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Cell-associated plasminogen activation: regulation and physiological functions

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1.

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Forestalling fibrosis

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Angiotensin II and IV stimulate expression and release of plasminogen activator inhibitor-1 in cultured human coronary artery endothelial cells

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Role of the angiotensin AT(1) receptor in rat aortic and cardiac PAI-1 gene expression

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Effects of angiotensins II and IV on blood pressure, renal function, and PAI-1 expression in the heart and kidney of the rat.

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Losartan inhibits the angiotensin II-induced modifications on fibrinolysis and matrix deposition by primary human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Angiotensin IV Activates the Nuclear Transcription Factor-κB and Related Proinflammatory Genes in Vascular Smooth Muscle Cells

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Characterization of two polyclonal peptide antibodies that recognize the carboxy terminus of angiotensin II AT1A and AT1B receptors

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Norepinephrine-induced changes in cardiac transforming growth factor-beta isoform expression pattern of female and male rats

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Norepinephrine enhances fibrosis mediated by TGF-beta in cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Molecular basis of renal fibrosis

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Regression of existing glomerulosclerosis by inhibition of aldosterone

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Deferential roles of angiotensin receptor subtypes in adrenocortical function in mice

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Persistent cardiac aldosterone synthesis in angiotensin II type 1A receptor-knockout mice after myocardial infarction

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Cross talk between angiotensin AT1 and alpha 1-adrenergic receptors: angiotensin II downregulates alpha 1a-adrenergic receptor subtype mRNA and density in neonatal rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo.

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Comparison of the vascular and antiadrenergic activities of four angiotensin II type 1 antagonists in the pithed rat.

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Reduction of vascular noradrenaline sensitivity by AT1 antagonists depends on functional sympathetic innervation

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021

Tissue- and agonist-specific regulation of human and murine plasminogen activator inhibitor-1 promoters in transgenic mice

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5002268

7 January 2021